Home What we do Patient engagement Diversity, equity, and inclusion (DE&I)

Diversity, equity, and inclusion.

The challenges we address.

Healthcare strategies, products, interactions, and activities must be inclusive, accessible, and reflective of diverse patient populations. We understand that improving DE&I within drug development has huge benefits to society, especially for hard-to-reach and underserved communities.

In addition, doing better with DE&I leads us to more robust science and research, improving healthcare and outcomes for everybody.

What we do.

The pharmaceutical industry is rapidly evolving in this space, and we support you in this changing environment to ensure that DE&I is integrated into strategies, processes, and solution development.

We are committed to ensuring that all patient and caregiver voices are heard, respected, and valued.

Our DE&I services include:

  • Health literacy training
  • Diversity, equity, and inclusion needs assessment
  • Diversity action plan development
  • Variety of patient research methodologies to gather patient insights from a diverse and representative population
  • Inclusive approaches to co-creation and collaboration initiatives
  • Diversity planning for clinical trials
  • Community outreach and engagement support
  • Inclusive and accessible patient materials
  • Translation and localization support

Latest thinking across MEDiSTRAVA.

We are thought leaders in the industry, driving the conversation and challenging our peers.

Read more about what our experts have to say.

Related solutions.

Contact us.

Learn more about MEDiSTRAVA’s strategic solutions and how we can help your business tackle the unique and evolving needs of leadership and Medical teams.